|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01858 CHUNLI MEDICAL
Nominal 
15.630 -0.290 (-1.822%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 487,596 | 28.271% | 380,131 | 540,707 | 571,392 | 482,632 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (35,034) | 451.444% | (6,353) | (7,582) | (12,817) | (10,238) | |
| Profit / (Loss) on Disposal | 4 | -90.187% | 39 | -- | 25 | 8 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 127,313 | 53.259% | 83,070 | 138,537 | 172,397 | 182,250 | |
| Taxation | (12,831) | 212.269% | (4,109) | (12,552) | (15,415) | (26,695) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (12) | -- | 65 | 92 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 114,469 | 44.850% | 79,026 | 126,077 | 156,982 | 155,555 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (6,743) | -25.179% | (9,012) | (4,994) | (5,778) | (5,350) |
| Depreciation & Amortisation | 20,011 | 7.299% | 18,650 | 16,176 | 13,287 | 8,727 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 30.000 | 42.857% | 21.000 | 33.000 | 41.000 | 45.000 |
| DPS (cts) | 0.000 | -- | 8.300 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 39.524% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 7.608 | -- | 7.346 | 7.106 | 6.704 | 3.571 |
| Remarks: | Real time quote last updated: 30/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 114,469 |
| %Change | 44.850% |
| EPS / (LPS) | RMB 0.300 |
| NBV Per Share (¥) | RMB 7.608 |